apriltwentyfoureightk.htm




UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549


FORM 8-K


CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
 
Date of report (Date of earliest event reported):  April 24, 2008


(Exact name of registrant as specified in its charter)


New Jersey
I-3215
22-1024240
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)


One Johnson & Johnson Plaza, New Brunswick, New Jersey  08933
(Address of Principal Executive Offices) (Zip Code)

Registrant’s telephone number, including area code:  732-524-0400

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 

o           Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o           Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o           Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o           Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 
 

 



Item 5.02.  Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
 
On April 24, 2008, the Board of Directors of Johnson & Johnson (the “Company”) accepted the resignation of Mr. Steven S Reinemund as a Director of the Company, effective immediately.  On April 22, 2008, Wake Forest University announced Mr. Reinemund as the new dean of the Calloway School of Business and Accountancy and the Babcock Graduate School of Management and Professor of Leadership and Strategy, effective July 1, 2008.  Mr. Reinemund was elected to the Board of Directors of the Company in 2003.


 
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
Johnson & Johnson
 
   
 (Registrant)
 
 
 
 
Date:  April 24, 2008
By:
/s/ Steven M. Rosenberg
 
   
Steven M. Rosenberg
 
   
Secretary